Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ASX/LGP stock hub

ASX/LGP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/LGPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

30.3M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/LGP

In the news

Latest news · ASX/LGP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/E5.1

P25 14.2P50 19.2P75 35.1

ROE7.4

P25 -118.7P50 -49.4P75 -1.2

ROIC-0.4

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/LGP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

186

Groups with data

Currency

AUD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	94
Employees Change	-26%
Employees Change Percent	-21.67
Enterprise value	AUD 32.9M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	AU0000074924
Last refreshed	2026-05-10
Market cap	AUD 30.3M
Price	AUD 0.1
Price currency	AUD
Sector	Healthcare
Sic	2834
Symbol	asx/LGP
Website	https://www.littlegreenpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	19.34%
EV Earnings	5.62x
EV/EBITDA	12.46x
EV/FCF	-17.27x
EV/Sales	0.85x
FCF yield	-6.29%
P/B ratio	0.35x
P/E ratio	5.13x
P/S ratio	0.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1.23%
EBITDA Margin	6.86%
Gross margin	71.63%
Gross Profit	AUD 27.6M
Gross Profit Growth	10.56%
Gross Profit Growth Q	21.97%
Gross Profit Growth3 Y	9.68%
Gross Profit Growth5 Y	14.85%
Net Income	AUD 5.9M
Net Income Growth Years	2%
Pretax Margin	-5.87%
Profit Margin	15.21%
Profitable Years	1
ROA	-0.33
ROCE	-0.52
ROE	7.38
ROIC	-0.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-13.92%
Cagr3y	-17.29%
Cagr5y	-31.78%
EPS Growth Years	2
OCF Growth Q	-68.84%
Revenue Growth	26.76x
Revenue Growth Q	9.42x
Revenue Growth Quarters	11x
Revenue Growth Years	7x
Revenue Growth3 Y	12.38x
Revenue Growth5 Y	14.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.43
Assets	AUD 97.6M
Cash	AUD 2.3M
Current Assets	AUD 24.2M
Current Liabilities	AUD 7.6M
Debt	AUD 4.9M
Debt EBITDA	AUD 1.86
Debt Equity	AUD 0.06
Debt FCF	AUD -2.58
Equity	AUD 86M
Interest Coverage	-1.48
Liabilities	AUD 11.6M
Long Term Assets	AUD 73.4M
Long Term Liabilities	AUD 4M
Net Cash	AUD -2.6M
Net Cash By Market Cap	AUD -8.65
Net Debt EBITDA	AUD 0.99
Net Debt Equity	AUD 0.03
Tangible Book Value	AUD 84.7M
Tangible Book Value Per Share	AUD 0.28
WACC	5.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.19
Inventory Turnover	0.71
Net Working Capital	AUD 15.5M
Quick ratio	0.73
Working Capital	AUD 16.6M
Working Capital Turnover	AUD 2.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-13.91%
200-day SMA	0.12
3Y total return	-43.43%
50-day SMA	0.1
50-day SMA vs 200-day SMA	50under200
5Y total return	-85.22%
All Time High	1.02
All Time High Change	-90.27%
All Time High Date	2021-02-04
All Time Low	0.08
All Time Low Change	30.26%
All Time Low Date	2024-09-05
ATR	0
Beta	0.26
Beta1y	-0.3
Beta2y	0.24
Ch YTD	-20.8
High	0.1
High52	0.15
High52 Date	2025-10-01
High52ch	-31.72%
Low	0.1
Low52	0.09
Low52 Date	2026-03-23
Low52ch	12.5%
Ma50ch	0%
Price vs 200-day SMA	-16.67%
RSI	52.02
RSI Monthly	38.78
RSI Weekly	40.77
Sharpe ratio	-0.07x
Sortino ratio	-0.01
Total Return	-0.95%
Tr YTD	-20.8
Tr1m	-1%
Tr1w	1.02%
Tr3m	-19.18%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -472,000
Operating margin	-1.23

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	230,341,851%
Net Borrowing	-96,000
Shares Insiders	16.18%
Shares Institutions	22.94%
Shares Out	305,855,910
Shares Qo Q	0.45%
Shares Yo Y	0.95%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -4.1M
Average Volume	93,701.35x
Bv Per Share	0.28
CAPEX	AUD -480,000
Ch1m	-1
Ch1w	1.02
Ch1y	-13.91
Ch3m	-19.18
Ch3y	-43.43
Ch5y	-85.22
Ch6m	-23.85
Change	3.13%
Change From Open	1.02
Close	0.1
Days Gap	2.08
Depreciation Amortization	3,113,000
Dollar Volume	11,568.6
Earnings Date	2026-05-12
EBIT	AUD -472,000
EBITDA	AUD 2.6M
EPS	AUD 0.02
F Score	4
FCF	AUD -1.9M
FCF EV Yield	-5.79x
FCF Per Share	AUD -0.01
Financing CF	-96,000
Fiscal Year End	March
Founded	2,016
Goodwill	856,000
Graham Number	0.34943
Graham Upside	253
Income Tax	AUD -8.1M
Investing CF	-1,017,000
Is Primary Listing	1
Last Earnings Date	2026-02-18
Last Report Date	2025-09-30
Ma150	0.12
Ma150ch	-16.17%
Ma20	0.1
Ma20ch	2.17%
Net CF	-2,532,000
Next Earnings Date	2026-05-12
Open	0.1
Position In Range	100
Ppne	60,488,000
Price Date	2026-05-08
Price EBITDA	AUD 11.47
Ptbv Ratio	0.36
Relative Volume	1.31x
Revenue	38,493,000x
SBC By Revenue	5.76x
Share Based Comp	2,217,000
Tax By Revenue	-21.08x
Tr6m	-23.85%
Volume	116,855
Z Score	2.03

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/LGP pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/LGP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/LGP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.9%

Share of float held by funds and institutions

Insider ownership

+16.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.0%

Negative means the company is buying back shares.

Technical

ASX/LGP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.0

Neutral momentum band

Price vs 200-day MA

-16.7%

50/200-day relationship not available

Beta (5Y)

0.26

Less volatile than the market

Sharpe ratio

-0.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/LGP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/LGP stock rating?

asx/LGP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/LGP analysis?

The full report lives at /stocks/asx/LGP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/LGP?

The latest report frames asx/LGP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/LGP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.